NOVOPEN Echo Plus Insulin Pen

Product Information

Each NovoPen ® 6 and NovoPen Echo ® Plus is expected to last four to five years. NovoPen ® 6 / NovoPen Echo ® Plus comes with a three-year full guarantee and Novo Nordisk will replace any pens that are faulty within that period. Dr Griffin adds that he is also now seeing the benefits of device connectivity in clinics. “The rich data has allowed me to have more meaningful consultations that are beneficial for the person living with type 1 diabetes and their families. I have been using an insulin pump for just over six months now, but before then I was using Novo smart pens. I would use the Echo Plus for my rapid-acting insulin injections, and the NovoPen 6 for my long-acting insulin. Pinder Sahota, General Manager, Novo Nordisk UK, said: “We believe digital innovation of devices and treatments has the potential to transform people’s lives and help alleviate the daily burden of living with diabetes.

Your quick guide to using NovoPen 6 or NovoPen Echo Plus

Visit www.diabeteswhatsnext.ie for more information on living with diabetes and NovoPen ® 6 and NovoPen Echo ® Plus smart insulin pens. Diabetes Novo Nordisk NovoPen NovoPen Ech Commenting on the interoperability between the smart pens and FreeStyle LibreLink, James says: “I have found registering NovoPen devices onto the LibreLink app very simple for myself and people in my clinic. Results from an observational study indicate that using NovoPen 6 to administer their insulin could give people living with type 1 diabetes close to two extra hours of improved glucose levels (measured as HbA 1c 3.9 – 10.0 mmol/L) per day, with a reduction in time spent in hyperglycaemia (measured as HbA 1c >10 mmol/L) and level 2 hypoglycaemia (measured as HbA 1c <3.0 mmol/L). A further analysis looking at missed bolus doses (insulin that is specifically taken at mealtimes) indicated that NovoPen 6 decreased the average daily number of missed doses by 43% (p=0.002) by the end of the study. A leading global healthcare company has launched two smart connected insulin pens in the UK to improve the lives of people living with diabetes.On interoperability with connective devices, Dr Griffin says: “Traditionally a person living with diabetes could see their glucose data in one place and would have needed to keep a manual log of their insulin data – often on paper or on a different platform. Glooko: In January 2017,Novo Nordisk and Glooko announced a partnershipto develop digital diabetes tools together. Since that time, they have launched the Cornerstones4Care app, and the two will continue to work together as Novo Nordisk brings its connected insulin pens to market. Earlier this year, Glooko received FDA clearance for a basal insulin dosing advice app, and we hope to see that come to market at some point. Smart insulin pens can also connect with certain apps that let you keep your insulin dosages and blood glucose data in one place. This means you can look at the timing and dose of your insulin in relation to any food you’ve eaten or activity you’ve done to see how it has affected you. The data can also tell you how much insulin is still working in your body which can help you make decisions for unplanned activity or unexpected sugar readings. The two smart connected insulin pens now allow healthcare professionals to view the insulin dosing information of people with diabetes, helping to facilitate more productive consultations and support personalised treatment guidance.

Instructions for use - Novo Nordisk

The devices have a dose memory display which shows the amount of time that has passed since the last dose, and they can show a person when a dose has been missed. Our smart connected insulin pens aim to empower people to better understand their diabetes management, have more informed conversations with their doctor and ultimately improve their blood glucose control.” Everyone with type 1 diabetes, and some people with type 2 diabetes or gestational diabetes, needs to take insulin to help manage their blood glucose levels. This reduces the chances of getting the symptoms of high blood glucose ( hyperglycaemia) and serious long-term problems that can damage the heart, kidneys, eyes, nerves and feet. NovoPen ® 6 and NovoPen Echo ® Plus automatically record accurate and reliable insulin dosing information, giving people insight into their own data, and enabling more productive conversations with their healthcare provider, that can lead to better health outcomes.pre-filled pens containing insulin degludec combined with liraglutide, for people with type 2 diabetes who need both medicines They come in different brands and are used with different types of insulin pen, but they all work in a similar way. Once your smart insulin pen is connected to an integrated app, this information can then be sent virtually to help people manage their insulin data more easily and in one place. Long-acting insulin starts to work after 30 minutes to 4 hours, depending on the type. It usually lasts for 16 to 24 hours, depending on the type and your dose. You'll usually take it once or twice a day.

Patient | NOVOPEN® 6 and NOVOPEN ECHO® PLUS

For me, the best thing was that it became a safety net in terms of knowing when I last injected insulin. Before insulin pump therapy I had injected over 15,000 times during 10 years with type 1 diabetes and there were times when I would ask myself 'did I give my insulin?'. NovoPens provided me with that answer, which helped to keep me safe.” Providing your smartphone or tablet supports Near Field Communication (NFC) then Novo’s smart pens can be connected with the following apps: Tom began using the Libre sensor alongside smart insulin pens in February 2022. He admits that prior to FreeStyle LibreLink connectivity being made available with the pens, using Glooko to link up the smart pen alongside LibreLink for sensor readings was useful, but also a challenge. This was because he had to navigate multiple apps at the same time. But he says the FreeStyle LibreLink integration of smart insulin pens is a ‘massive improvement’.

Thank you for subscribing

This data can be uploaded to a compatible app and viewed by people living with diabetes and their healthcare professionals. The kid-friendly Echo Plus allows for half-unit dosing and a maximum 30-unit injection, whereas the NovoPen 6 has a minimum dose of one unit and a maximum dose of 60 units. Over time, these new connected pens will replace the NovoPen 5 and current NovoPen Echo. Attachment for Disposable Pens Manually logging data is time consuming. It typically did not show the exact time that insulin was administered, for example, before or after a meal was consumed. Smart connected devices reduce this time spent logging and provide more precise data.”

NovoPen 6 and NovoPen Echo Plus: Connected Insulin Pens To NovoPen 6 and NovoPen Echo Plus: Connected Insulin Pens To

Data from NovoPen ® 6 and NovoPen Echo ® Plus smart insulin pens can be wirelessly transferred via NFC technology and are compatible with various diabetes management apps and existing in-clinic solutions, where injection history can be viewed side by side with glucose information. Patients can easily share their data with their diabetes team.

GlobalData

Reusable Novo Nordisk smart insulin pens will launch first, followed by a Bluetooth attachment for disposable pens later in 2019. Partners include Roche/mySugr, Dexcom, and Glooko Insulin treats the symptoms of diabetes by lowering your blood glucose. But it can sometimes cause your blood glucose to go too low. This is known as hypoglycaemia, or hypos. Make sure you know the symptoms of a hypo, and always carry a source of glucose with you, such as sugary sweets, in case you need to treat a hypo.